Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-human CD19 Antibody (8G840)

😃Good
Catalog No. TMAB-07390

Anti-human CD19 Antibody (8G840) is a Mouse antibody targeting human CD19. Anti-human CD19 Antibody (8G840) can be used in FCM.

Anti-human CD19 Antibody (8G840)

Anti-human CD19 Antibody (8G840)

😃Good
Catalog No. TMAB-07390
Anti-human CD19 Antibody (8G840) is a Mouse antibody targeting human CD19. Anti-human CD19 Antibody (8G840) can be used in FCM.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
100 μg$3547-10 days7-10 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-human CD19 Antibody (8G840) is a Mouse antibody targeting human CD19. Anti-human CD19 Antibody (8G840) can be used in FCM.
Ig Type
Mouse IgG1
Clone
8G840
Reactivity
Human
Application
Recommended Dose
FCM: 1μg/Test
Antibody Type
Monoclonal
Host SpeciesMouse
Subcellular LocalizationMembrane; Single-pass type I membrane protein.
ConstructionHybridoma Monoclonal Antibody
PurificationProtein G purified
AppearanceLiquid
Formulation0.01M TBS (pH7.4).
Concentration1mg/ml
Research BackgroundThis gene encodes a member of the immunoglobulin gene superfamily. Expression of this cell surface protein is restricted to B cell lymphocytes. This protein is a reliable marker for pre-B cells but its expression diminishes during terminal B cell differentiation in antibody secreting plasma cells. The protein has two N-terminal extracellular Ig-like domains separated by a non-Ig-like domain, a hydrophobic transmembrane domain, and a large C-terminal cytoplasmic domain. This protein forms a complex with several membrane proteins including complement receptor type 2 (CD21) and tetraspanin (CD81) and this complex reduces the threshold for antigen-initiated B cell activation. Activation of this B-cell antigen receptor complex activates the phosphatidylinositol 3-kinase signalling pathway and the subsequent release of intracellular stores of calcium ions. This protein is a target of chimeric antigen receptor (CAR) T-cells used in the treatment of lymphoblastic leukemia. Mutations in this gene are associated with the disease common variable immunodeficiency 3 (CVID3) which results in a failure of B-cell differentiation and impaired secretion of immunoglobulins. CVID3 is characterized by hypogammaglobulinemia, an inability to mount an antibody response to antigen, and recurrent bacterial infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2020]
Antigen Details
Immunogen
KLH conjugated synthetic peptide: human CD19
Antigen Species
Human
Gene Name
CD19
Gene ID
Protein Name
B-lymphocyte antigen CD19
Uniprot ID
Function
Assembles with the antigen receptor of B-lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
Chemical Properties
Molecular WeightTheoretical: 59 kDa. Actual: 90 kDa.
Stability & Storage
Stability & StorageStore at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles.
TransportShipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Anti-human CD19 Antibody (8G840) | purchase Anti-human CD19 Antibody (8G840) | Anti-human CD19 Antibody (8G840) cost | order Anti-human CD19 Antibody (8G840) | Anti-human CD19 Antibody (8G840) molecular weight